Loreal 2013 Annual Report Download - page 74

Download and view the complete annual report

Please find page 74 of the 2013 Loreal annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 96

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96

2013 was the year in which GALDERMA accelerated its expansion
and reasserted its exclusive commitment to dermatology.
This commitment is at the heart of its new identity – the logo
stresses dermatology, which is GALDERMA’s DNA –, and of its
institutional communication that brings together people
and science.
A DIFFERENTIATED STRATEGY
WITH THREE SECTORS OF ACTIVITY
To take on board the changing paradigm of the pharma-
ceutical industry and the growing importance of generics,
GALDERMA has devised a differentiated strategy based on
three pillars: prescription drugs, self-medication products,
and aesthetic and corrective medical solutions. Each of
these businesses has specific development models and
stakeholder relationships. But they share a common object-
ive: stepping up innovation in the interest of patients and
healthcare professionals.
A major player in its market, GALDERMA is implementing its strategy in three fields
of activity, and extending its unique portfolio of medical solutions to meet
the dermatological needs of people, throughout their lifetime, while serving healthcare
professionals all over the world.
⁄ GALDERMA,
COMMITTED TO THE FUTURE
OF DERMATOLOGY
Epiduo
®
strengthens its position
as the No.1 topical prescription
treatment for acne
(1).
72
GALDERMA